CFM
RCEL icon

Catalyst Funds Management’s Avita Medical RCEL Stock Holding History

Catalyst Funds Management’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-400
Closed -$4.29K – 1055
2024
Q3 		$4.29K Hold
400
– – ﹤0.01% 1245
2024
Q2 		$3.17K Buy
+400
New +$3.81K ﹤0.01% 1103

Other funds holding RCEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Catalyst Funds Management's RCEL Position: Q4 2024 in Review

Catalyst Funds Management sold out of Avita Medical (RCEL) in Q4 2024, closing a stake of 400 shares — an estimated $4.29K sold.

Catalyst Funds Management first reported a position in RCEL in Q2 2024 and held it in 2 quarters. The position peaked at $4.29K in Q3 2024. 73 funds tracked by Wall St. Rank hold RCEL as of Q4 2024.

  • Catalyst Funds Management reported no remaining Avita Medical position as of Q4 2024 after selling out during the quarter.
  • Catalyst Funds Management sold 400 Avita Medical shares in Q4 2024, an estimated $4.29K.
  • Catalyst Funds Management first reported a position in Avita Medical in Q2 2024 and held it in 2 quarters.
  • Catalyst Funds Management's Avita Medical position peaked at $4.29K in Q3 2024.
  • 73 funds tracked by Wall St. Rank held Avita Medical as of Q4 2024.

Based on Catalyst Funds Management's 13F filing for Q4 2024, filed 10 Feb 2025.